42 patents
Page 3 of 3
Utility
E-selectin antagonist compounds, compositions, and methods of use
6 Jan 20
Methods and compositions using E-selectin antagonists are provided for the treatment and prevention of diseases and disorders treatable by inhibiting binding of E-selectin to an E-selectin ligand.
John L. Magnani, Arun K. Sarkar, Myung-Gi Baek, Frank E. Anderson, III, Yanhong Li
Filed: 18 Sep 17
Utility
Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
30 Dec 19
Compounds, compositions, and methods for treatment and/or prevention of cancer and inflammatory diseases, and for releasing cells such as stem cells (e.g., bone marrow progenitor cells) into circulating blood and enhancing retention of the cells in the blood are disclosed.
John L. Magnani, Arun K. Sarkar, John M. Peterson
Filed: 30 Nov 15